Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin

Inflammation Research

Volumn 52, Issue 9, 2003, Pages 372-377

  Petersen, L J ^a,b   Skov, P S ^c  

^a BISPEBJERG HOSPITAL   (Denmark)

^b University of Copenhagen ^*  (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Beta adrenergic agonists; Histamine; Immediate type hypersensitivity; Randomized controlled trial; Skin tests

Indexed keywords

ALLERGEN; BAMBUTEROL; CODEINE; HISTAMINE; PLACEBO; PROSTAGLANDIN D2; TERBUTALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HISTAMINE RELEASE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IN VIVO STUDY; INHIBITION KINETICS; MALE; MAST CELL DEGRANULATION; MICRODIALYSIS; PROSTAGLANDIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; SKIN ALLERGY; SKIN MANIFESTATION; URTICARIA;

ADMINISTRATION, ORAL; ADRENERGIC BETA-AGONISTS; ADULT; ANTI-INFLAMMATORY AGENTS; FEMALE; HISTAMINE RELEASE; HUMANS; HYPERSENSITIVITY; INJECTIONS, INTRADERMAL; MALE; SKIN; TERBUTALINE; TIME FACTORS;

EID: 0141630500     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-003-1187-3     Document Type: Article

References (30)

1. Svedmyr N, Lofdahl CG. The use of beta 2-adrenoceptor agonists in the treatment of bronchial asthma. Pharmacol Toxicol 1996; 78: 3-11.
2. Okayama Y, Church MK. Drugs modifying the responses of mast cells and basphils. In: Foreman JC, ed. Immunopharmacology of Mast Cells and Basophils. London: Academic Press, 1993: 139-52.
3. Martin GL, Atkins PC, Dunsky EH, Zweiman B. Effects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release. J Allergy Clin Immunol 1980; 66: 204-12.
4. Howarth PH, Durham SR, Lee TH, Kay AB, Church MK, Holgate ST. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Am Rev Respir Dis 1985; 132: 986-92.
5. Charlesworth EN. The skin as a model to study the pathogenesis of IgE-mediated acute and late-phase responses. J Allergy Clin Immunol 1994; 94: 1240-50.
6. Zweiman B. Skin chamber techniques. In: Setup J, Jemec GBE, eds. Handbook of Non-invasive Methods and the Skin. Boca Raton: CRC Press, Inc., 1995: 633-9.
7. Ting S, Zweiman B, Lavker R. Terbutaline modulation of human allergic skin reactions. J Allergy Clin Immunol 1983; 71: 437-41.
8. Grönneberg R, van Hage-Hamsten M, Halldén G, Hed J, Raud J. Effects of salmeterol and terbutaline on IgE-mediated dermal reactions and inflammatory events in skin chambers in atopic patients. Allergy 1996; 51: 640-6.
9. Grönneberg R, Strandberg K, Hägermark Ö. Cutaneous responses to allergen after local pretreatment with beta- adrenoceptor stimulating and blocking agents. Allergy 1980; 35: 409-12.
10. Grönneberg R, Raud J. Effects of local treatment with salmeterol and terbutaline on anti-IgE-induced wheal, flare, and late induration in human skin. Allergy 1996; 51: 685-92.
11. Abramowitz PW, Perez MM, Johnson CE, McLean JA. Effect of theophylline, terbutaline, and their combination on the immediate hypersensitivity skin-test reaction. J Allergy Clin Immunol 1980; 66: 123-8.
12. Grönneberg R, Hägermark Ö, Strandberg K. Effect in man of oral terbutaline on cutaneous reactions induced by allergen and cold stimulation. Allergy 1980; 35: 143-7.
13. Petersen LJ. Measurement of histamine release in intact human skin in vivo by microdialysis technique. Clinical and experimental findings. Dan Med Bull 45, 383-401. 1998.
14. Petersen LJ, Skov PS. The effect of salmeterol and salbutamol on mediator release and skin responses in immediate and late phase allergic cutaneous reactions. Inflamm Res 1999; 48: 527-32.
15. Petersen LJ, Poulsen LK, Sondergaard J, Skov PS. The use of cutaneous microdialysis to measure substance P-induced histamine release in intact human skin in vivo. J Allergy Clin Immunol 1994; 94: 773-83.
16. Poulsen LK, Liisberg C, Bindslev Jensen C, Malling HJ. Precise area determination of skin-prick tests: validation of a scanning device and software for a personal computer. Clin Exp Allergy 1993; 23: 61-8.
17. Cazzola M, Calderaro F, Califano C, Di Pema F, Vinciguerra A, Donner CF et al. Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease. Eur J Clin Pharmacol 1999; 54: 829-33.
18. Crompton GK, Ayres JG, Basran G, Schiraldi G, Brusasco V, Eivindson A et al. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids. Am J Respir Crit Care Med 1999; 159: 824-8.
19. Gunn SD, Ayres JG, McConchie SM. Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma. ACROBATICS Research Group. Eur J Clin Pharmacol 1995; 48: 23-8.
20. Bissonnette EY, Befus AD. Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells. J Allergy Clin Immunol 1997; 100: 825-31.
21. Butchers PR, Vardey CJ, Johnson M. Salmeterol: a potent and long-acting inhibitor of TNF-alpha release from human mast cells. Br J Pharmacol 1991; 104: 672-6.
22. Church MK, Young KD. The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine. Br J Pharmacol 1983; 78: 671-9.
23. Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 1987; 90: 421-9.
24. Lau HY, Wong PL, Lai CK, Ho YK. Effects of long-acting beta 2-adrenoceptor agonists on mast cells of rat, guinea pig, and human. Int Arch Allergy Immunol 1994; 105: 177-80.
25. Okayama Y, Church MK. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. Int Arch Allergy Immunol 1992; 97: 216-25.
26. Grönneberg R. Inhibition of allergen-induced early reactions in atopic skin by salbutamol and theophylline. Agents Actions 1985; 16: 501-3.
27. Grönneberg R, Zetterström O. Inhibition of anti-IgE induced skin response in normals by formoterol, a new beta 2-adrenoceptor agonist, and terbutaline. 1. Dose response relation and duration of effect on the early wheal and flare response. Allergy 1990; 45: 334-9.
28. Rosenborg J, Larsson P, Nyberg L. Pharmacokinetics of bambuterol during oral administration of plain tablets and solution to healthy adults. Br J Clin Pharmacol 2000; 49: 199-206.
29. Sagi-Eisenberg R. Signal-transmission pathways in mast cell exocytosis. In: Foreman JC, ed. Immunopharmacology of Mast Cells and Basophils. London: Academic Press Limited, 1993: 71-88.
30. Crandall CG, Etzel RA, Johnson JM. Evidence of functional beta-adrenoceptors in the cutaneous vasculature. Am J Physiol 1997; 273: H1038-H1043.